Let's check out hedge fund and insider activity in other stocks similar to ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS). These stocks are United Therapeutics Corporation (NASDAQ:UTHR), Cubist Pharmaceuticals Inc (NASDAQ:CBST), Amarin Corporation plc ...

Cubist Pharmaceutical Inc. (NASDAQ: CBST) is the ultimate binary event play. With a critical court decision pending, the stock could have tremendous movement, depending on the outcome.

AstraZeneca Plc (AZN) and Cubist Pharmaceuticals Inc. (CBST) are among the suitors that made first-round bids for Optimer Pharmaceuticals Inc. (OPTR), the antibiotics maker weighing a sale, said people familiar with the matter.

However, other biopharmaceutical stocks such as Jazz Pharmaceuticals ( JAZZ ), Santarus Inc. ( SNTS ) and Cubist Pharmaceuticals Inc. ( CBST ) currently look more attractive. While, Jazz Pharma and Santarus carry a Zacks Rank #1 (Strong Buy), Cubist ...

On May 13, 2013, Trius Therapeutics (TSRX) announced that it had received a notice of allowance from the USPTO for a patent application relating to the use of its tedizolid phosphate antibiotic in combination with Cubist Pharmaceuticals' (CBST ...

The companies that look better-positioned include Osiris Therapeutics (OSIR) and Cubist Pharmaceuticals Inc. (CBST). Both are Zacks Rank #2 (Buy) stocks.

ComScore Inc. (NASDAQ: SCOR) was raised to Buy from Hold at Cantor Fitzgerald. Cubist Pharmaceuticals Inc. (NASDAQ: CBST) was initiated with a Buy rating at UBS.

Before Optimer Pharmaceuticals Inc even put itself up for sale earlier this year, Cubist Pharmaceuticals Inc offered to buy the antibiotic maker for $20 per share, or nearly $1 billion, two people familiar with the matter told Reuters on Wednesday ...

Optimer Pharmaceuticals, Inc. (NASDAQ:OPTR) rose 13.54% to $16.18 and ranged between $13.95 and $16.80, scoring sharp gains in final hours after Reuters reported that Cubist Pharmaceuticals Inc offered to buy Optimer Pharmaceuticals Inc for $20 per ...

Apart from Celgene, other stocks with favorable Zacks Rank include Athersys, Inc. ( ATHX ), Isis Pharmaceuticals, Inc. ( ISIS ) and Cubist Pharmaceuticals Inc. ( CBST ). While Athersys carries a Zacks Rank #1 (Strong Buy), Isis Pharma and Cubist Pharma ...